C07D 307/24
Carbon atoms having three bonds to hetero atoms with at the most
Official title: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
C07D307/24 (Carbon atoms having three bonds to hetero atoms with at the most) appears on 261 US grants and 188 published applications in this corpus.
Search patents in C07D- Granted patents
- 261
- Published applications
- 188
- Assignees
- 156
- Inventors
- 980
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 2 | 0 |
| 1978 | 54 | 0 |
| 1979 | 6 | 0 |
| 1980 | 3 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 3 | 0 |
| 1984 | 8 | 0 |
| 1985 | 4 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 6 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 6 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 7 | 0 |
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 6 | 1 |
| 2002 | 8 | 7 |
| 2003 | 8 | 7 |
| 2004 | 7 | 14 |
| 2005 | 2 | 7 |
| 2006 | 4 | 8 |
| 2007 | 1 | 7 |
| 2008 | 7 | 3 |
| 2009 | 2 | 8 |
| 2010 | 5 | 9 |
| 2011 | 2 | 5 |
| 2012 | 6 | 7 |
| 2013 | 7 | 3 |
| 2014 | 6 | 13 |
| 2015 | 8 | 2 |
| 2016 | 2 | 13 |
| 2017 | 9 | 8 |
| 2018 | 7 | 8 |
| 2019 | 7 | 5 |
| 2020 | 2 | 9 |
| 2021 | 6 | 6 |
| 2022 | 4 | 4 |
| 2023 | 5 | 12 |
| 2024 | 4 | 10 |
| 2025 | 3 | 6 |
| 2026 | 7 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Treprostinil derivatives and compositions and uses thereof2 Jun 2026US 12,643,847 B2Corsair Pharma, Inc.
- Arylamides and methods of use thereof26 May 2026US 12,637,414 B2Genzyme Corporation
- Interleukin-17 (IL-17) inhibitors26 May 2026US 12,637,430 B2Hitgen Inc.
- Glutamine analogs17 Mar 2026US 12,577,201 B2Jacobio Pharmaceuticals Co., Ltd.
- FABP4/5 inhibitors, methods of use and methods of making10 Mar 2026US 12,570,603 B2Celloram Inc.
- Sigma-1 receptor ligands and use thereof17 Sep 2026US 2026/0274811 A1
- Fabp4/5 inhibitors, methods of use and methods of making14 May 2026US 2026/0132106 A1Celloram Inc.
- Heterocyclic compound, method for preparing same, and pharmaceutical use thereof26 Feb 2026US 2026/0055088 A1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Organonickel intermediates useful for carboxylation of substrates with carbon dioxide26 Feb 2026US 2026/0055128 A1Alliance for Sustainable Energy, LLC
- Preparation method for intermediate compound acting as synthetic posaconazole, and intermediate compound prepared thereby29 Jan 2026US 2026/0028322 A1Zhejiang Ausun Pharmaceutical Co., Ltd.
Most cited
By later US patents
- Aryl phenyl substituted cyclic ketoenols94US 6,458,965 B1Bayer Aktiengesellschaft · 2002
- 7, 9-substituted tetracycline compounds85US 6,683,068 B2Paratek Pharmaceuticals, Inc. · 2004
- Processes for the diastereoselective synthesis of nucleoside analogues52US 5,756,706 ABioChem Pharma Inc. · 1998
- Processes for the diastereoselective synthesis of nucleoside analogues51US 5,696,254 ABioChem Pharma Inc. · 1997
- N-(2-benzimidazolyl)-piperazines47US 4,093,726 AAbbott Laboratories · 1978